The Cigna Group (CI) Set to Announce Earnings on Thursday

The Cigna Group (NYSE:CI) will be posting its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect The Cigna Group to post earnings of $6.16 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm had revenue of $51.15 billion for the quarter, compared to analyst estimates of $48.91 billion. During the same quarter in the prior year, the company posted $4.96 earnings per share. The Cigna Group’s quarterly revenue was up 11.8% on a year-over-year basis. On average, analysts expect The Cigna Group to post $28 EPS for the current fiscal year and $32 EPS for the next fiscal year.

The Cigna Group Stock Performance

NYSE:CI opened at $356.53 on Tuesday. The stock has a market cap of $104.24 billion, a PE ratio of 20.50, a price-to-earnings-growth ratio of 1.09 and a beta of 0.56. The Cigna Group has a fifty-two week low of $240.50 and a fifty-two week high of $365.71. The firm’s fifty day simple moving average is $350.19 and its 200-day simple moving average is $318.58. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61.

The Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be paid a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a dividend yield of 1.57%. The ex-dividend date of this dividend is Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 32.20%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CI. Barclays initiated coverage on shares of The Cigna Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price objective on the stock. Sanford C. Bernstein raised The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $330.00 to $372.00 in a research report on Thursday, January 4th. Royal Bank of Canada raised shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $327.00 to $354.00 in a research report on Monday, February 5th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th. Finally, Mizuho boosted their price target on The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a report on Monday, February 5th. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $362.14.

Insider Transactions at The Cigna Group

In related news, CEO David Cordani sold 38,065 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $335.22, for a total value of $12,760,149.30. Following the sale, the chief executive officer now directly owns 329,321 shares in the company, valued at approximately $110,394,985.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Eric P. Palmer sold 6,083 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $340.00, for a total value of $2,068,220.00. Following the completion of the sale, the insider now owns 44,649 shares in the company, valued at $15,180,660. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Cordani sold 38,065 shares of the stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the sale, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at $110,394,985.62. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 114,144 shares of company stock valued at $39,296,330. Corporate insiders own 0.70% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.